Vertex Pharmaceuticals Inc.

Insider Buying Week 08-08-25-Insiders are Shopping Pharma and Biotech

by

Insider buying picked up some this week. There are notable big names stocks that I can honestly say insiders are swinging the bat at but can you or I get excited about their prospects when the entire investing world revolves around AI and the enormous energy resources it will demand.  None the less we stick to our knitting, our discipline and write up this report even if we are not buying just yet.  But read on, you never know. It’s usually where the crowd is not looking, that the biggest returns are found. The bloodbath continues unabated in pharma and … Read more

Insider Buying week 8-27-21

by

For trade, details click on this link to the trades.  I had a dream Friday morning about the stock market. I yelled out in my sleep, “everything is going up.” I woke up and it pretty much did exactly that. In a good market, almost all trades bounce sharply but the stickiness and real progress from there are what you have to measure. Perhaps deduct 4 or 5 percent from all the posted returns to determine your likely return as getting them at the same price or lower than the insider’s purchase cost is difficult to do since they almost … Read more

Insider Buying Picks Up Dramatically Week 8-06-21

by

For trade, details click on this link to the trades.  Name Sachs Bruce I Position: Director Shares Bought: 15,000 Average Price Paid: $197.91, Cost: $2,968,650 Company: Vertex Pharmaceuticals Inc. (VRTX) Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease – and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has … Read more